Identification of novel mutations in CALR in ET and PMF patients with non-mutated JAK2 and MPL is another important step in this field but the mechanistic details of how CALR contributes to the development of MPN remains to be elucidated. The gene discussed is CALR; the disease is myeloproliferative disorder.